Glen Eagle Advisors’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30.5K | Hold |
645
| – | – | ﹤0.01% | 535 |
|
|
2026
Q1 | $38.2K | Hold |
645
| – | – | 0.01% | 486 |
|
|
2025
Q4 | $39.8K | Hold |
645
| – | – | 0.01% | 484 |
|
|
2025
Q3 | $40.2K | Hold |
645
| – | – | 0.01% | 484 |
|
|
2025
Q2 | $51.5K | Hold |
645
| – | – | 0.01% | 421 |
|
|
2025
Q1 | $55.5K | Buy |
+645
| New | +$52.9K | 0.01% | 397 |
|
|
2024
Q4 | – | Sell |
-645
| Closed | -$46.5K | – | 1146 |
|
|
2024
Q3 | $46.5K | Hold |
645
| – | – | 0.01% | 430 |
|
|
2024
Q2 | $44.4K | Buy |
+645
| New | +$43.7K | 0.01% | 423 |
|
|
2023
Q3 | – | Sell |
-645
| Closed | -$38.3K | – | 1063 |
|
|
2023
Q2 | $38.3K | Hold |
645
| – | – | 0.01% | 408 |
|
|
2023
Q1 | $40.4K | Hold |
645
| – | – | 0.01% | 397 |
|
|
2022
Q4 | $40.4K | Hold |
645
| – | – | 0.01% | 388 |
|
|
2022
Q3 | $32.1K | Hold |
645
| – | – | 0.01% | 411 |
|
|
2022
Q2 | $37.9K | Hold |
645
| – | – | 0.01% | 404 |
|
|
2022
Q1 | $34.1K | Hold |
645
| – | – | 0.01% | 431 |
|
|
2021
Q4 | $39.1K | Hold |
645
| – | – | 0.01% | 409 |
|
|
2021
Q3 | $36.2K | Hold |
645
| – | – | 0.01% | 431 |
|
|
2021
Q2 | $33.6K | Hold |
645
| – | – | 0.01% | 450 |
|
|
2021
Q1 | $28.4K | Hold |
645
| – | – | 0.01% | 446 |
|
|
2020
Q4 | $22.5K | Hold |
645
| – | – | 0.01% | 476 |
|
|
2020
Q3 | $23.5K | Sell |
645
-50
| -7% | -$1.86K | 0.01% | 436 |
|
|
2020
Q2 | $26.1K | Buy |
695
+50
| +8% | +$2K | 0.01% | 394 |
|
|
2020
Q1 | $23.7K | Hold |
645
| – | – | 0.02% | 378 |
|
|
2019
Q4 | $26.1K | Hold |
645
| – | – | 0.01% | 424 |
|
|
2019
Q3 | $22.4K | Hold |
645
| – | – | 0.01% | 400 |
|
|
2019
Q2 | $20.4K | Hold |
645
| – | – | 0.01% | 395 |
|
|
2019
Q1 | $19.3K | Sell |
645
-95
| -13% | -$2.72K | 0.01% | 388 |
|
|
2018
Q4 | $22.9K | Sell |
740
-210
| -22% | -$7.66K | 0.02% | 349 |
|
|
2018
Q3 | $36K | Sell |
950
-150
| -14% | -$5.67K | 0.03% | 305 |
|
|
2018
Q2 | $42.2K | Sell |
1,100
-105
| -9% | -$3.54K | 0.03% | 270 |
|
|
2018
Q1 | $40.6K | Sell |
1,205
-650
| -35% | -$24.9K | 0.03% | 269 |
|
|
2017
Q4 | $82.4K | Sell |
1,855
-6,395
| -78% | -$291K | 0.07% | 211 |
|
|
2017
Q3 | $413K | Sell |
8,250
-2,750
| -25% | -$140K | 0.39% | 59 |
|
|
2017
Q2 | $581K | Sell |
11,000
-850
| -7% | -$45.5K | 0.46% | 51 |
|
|
2017
Q1 | $660K | Hold |
11,850
| – | – | 0.57% | 41 |
|
|
2016
Q4 | $617K | Buy |
+11,850
| New | +$572K | 0.56% | 42 |
|
Other funds holding PBH
AI
BIP
Glen Eagle Advisors's PBH Position: Q2 2026 in Review
Glen Eagle Advisors held its Prestige Consumer Healthcare (PBH) position steady in Q2 2026 at 645 shares worth $30.5K. The position accounts for ﹤0.01% of the portfolio, ranked #535.
Glen Eagle Advisors first reported a position in PBH in Q4 2016 and has held it in 35 quarters since. The position peaked at $660K in Q1 2017. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Glen Eagle Advisors held 645 shares of Prestige Consumer Healthcare worth $30.5K as of Q2 2026.
- Glen Eagle Advisors left its Prestige Consumer Healthcare share count unchanged in Q2 2026.
- Prestige Consumer Healthcare made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #535 holding.
- Glen Eagle Advisors first reported a position in Prestige Consumer Healthcare in Q4 2016 and has held it in 35 quarters since.
- Glen Eagle Advisors's Prestige Consumer Healthcare position peaked at $660K in Q1 2017.
- 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.